IMMUNOPATHOGENESIS AND THERAPY OF SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:2
|
作者
KATER, L
GMELIGMEYLING, FHJ
DERKSEN, RHWM
DELAFAILLE, HB
机构
[1] UNIV UTRECHT HOSP,DEPT IMMUNOL,3508 GA UTRECHT,NETHERLANDS
[2] UNIV UTRECHT HOSP,DEPT DERMATOL,3508 GA UTRECHT,NETHERLANDS
来源
CLINICAL IMMUNOTHERAPEUTICS | 1995年 / 4卷 / 06期
关键词
D O I
10.1007/BF03259309
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aetiopathogenesis of systemic lupus erythematosus (SLE) is thought to comprise the combined action of hormonal influences and other factors, partly of exogenous and partly of endogenous nature, which leads to the production of autoantibodies and/or lymphoid cells, resulting in inflammatory processes, The fundamental characteristic is the occurrence in blood of autoantibodies against intranuclear cell components, usually designated as antinuclear antibodies, In addition, autoantibodies against cytoplasmically located antigens occur, Antibodies to DNA are the most prominent examples of autoantibodies, the most typical of which in SLE are antibodies to double-stranded DNA. Antibodies directed against different components of ribonucleoprotein particles include the anti-Sm, anti-SS-A (Ro) and anti-SS-B (La) antibodies. Antihistone antibodies directed against DNA-binding proteins, in particular against various histones, occur frequently in patients with drug-induced lupus, Antiphospholipid antibodies, notably lupus anticoagulant and anticardiolipin antibodies, are strongly associated with the antiphospholipid syndrome, but these antibodies can also occur in patients without features of lupus. This wide spectrum of autoantibodies implies a marked degree of chronic B lymphocyte activity. The question is whether these findings point to an intrinsic B cell aberration, There is also considerable evidence for a role of T cells in the pathogenesis of SLE, In addition, unbalanced cytokine production seems to occur, The disease also has genetic and gender aspects, and its activity may be modulated by sex hormones. Unfortunately, as the aetiology of SLE is still obscure and the pathogenetic mechanisms leading to organ disease not well understood, therapy is still limited to the use of agents with rather nonspecific anti-inflammatory properties, such as antimalarials, corticosteroids. cytotoxic drugs and apheresis. Most of these therapeutic modalities may not only benefit but also cause serious adverse effects. The eventual aim is to design immune intervention strategies, such as specific blocking peptides, by which harmful immune reactions will be eliminated leaving host defence immune reactivity intact. However, the most logical approach for immune intervention in the treatment of SLE has still to be defined.
引用
收藏
页码:471 / 493
页数:23
相关论文
共 50 条
  • [1] IMMUNOPATHOGENESIS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    KOFFLER, D
    BIESECKER, G
    KATZ, SM
    ARTHRITIS AND RHEUMATISM, 1982, 25 (07): : 858 - 861
  • [2] IMMUNOPATHOGENESIS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    KOFFLER, D
    ANNUAL REVIEW OF MEDICINE, 1974, 25 : 149 - 164
  • [3] RECENT ADVANCES IN IMMUNOPATHOGENESIS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    BARDANA, EJ
    PIROFSKY, B
    WESTERN JOURNAL OF MEDICINE, 1975, 122 (02): : 130 - 144
  • [4] SYSTEMIC LUPUS-ERYTHEMATOSUS - IMMUNOPATHOGENESIS OF NEUROLOGIC DYSFUNCTION
    MOORE, PM
    LISAK, RP
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1995, 17 (01): : 43 - 60
  • [5] IMMUNOPATHOGENESIS OF THE NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    BLUESTEIN, HG
    PISCHEL, KD
    WOODS, VL
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1986, 9 (2-3): : 237 - 249
  • [6] THERAPY OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    BANGO, MY
    NUNEZ, JAV
    GEABANACLOCHE, JC
    PIZARRO, YR
    REVISTA CLINICA ESPANOLA, 1995, 195 (01): : 50 - 61
  • [7] THERAPY FOR SYSTEMIC LUPUS-ERYTHEMATOSUS
    LOCKSHIN, MD
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (03): : 189 - 191
  • [8] FRENTIZOLE THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    SABHARWAL, UK
    VAUGHAN, JH
    KAPLAN, RA
    ROBINSON, CA
    CURD, JG
    ARTHRITIS AND RHEUMATISM, 1980, 23 (12): : 1376 - 1380
  • [9] THERAPY OF SEVERE SYSTEMIC LUPUS-ERYTHEMATOSUS
    SCHMIDT, RE
    WITTE, T
    DEICHER, H
    NEUMANN, KH
    SCHAUMANN, D
    KOCH, KM
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1991, 116 (49) : 1891 - 1892
  • [10] IMMUNOSUPPRESSIVE THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DEICHER, H
    MONATSSCHRIFT KINDERHEILKUNDE, 1972, 120 (06) : 249 - &